Amarin’s Vascepa Loses Patent Protection in Court Battle, Shares PlungeBusiness, District Courts, Fish Oil, Generics, Heart Disease, Legal, Patent Protection, Shares, TherapeuticsShares of Amarin Corporation were down more than 70 percent in trading after a judge ruled that generic companies can go ahead and seek approval of generic versions of the drug manufacturer’s heart disease drug Vascepa. Read more March 31, 2020/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/03/Amarins-Vascepa-Loses-Patent-Protection-BioSpace-3-31-20.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2020-03-31 12:25:042020-04-11 20:44:08Amarin’s Vascepa Loses Patent Protection in Court Battle, Shares Plunge